Global Betahistine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Betahistine market size was valued at US$ million in 2023. With growing demand in downstream market, the Betahistine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Betahistine market. Betahistine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Betahistine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Betahistine market.
Betahistine is an antivertigo drug first used for treating vertigo assosicated with Mйni?re's disease. It is also commonly used for patients with balance disorders.
Key Features:
The report on Betahistine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Betahistine market. It may include historical data, market segmentation by Type (e.g., 8mg, 25mg), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Betahistine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Betahistine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Betahistine industry. This include advancements in Betahistine technology, Betahistine new entrants, Betahistine new investment, and other innovations that are shaping the future of Betahistine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Betahistine market. It includes factors influencing customer ' purchasing decisions, preferences for Betahistine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Betahistine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Betahistine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Betahistine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Betahistine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Betahistine market.
Market Segmentation:
Betahistine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Betahistine market?
What factors are driving Betahistine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Betahistine market opportunities vary by end market size?
How does Betahistine break out type, application?
According to our LPI (LP Information) latest study, the global Betahistine market size was valued at US$ million in 2023. With growing demand in downstream market, the Betahistine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Betahistine market. Betahistine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Betahistine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Betahistine market.
Betahistine is an antivertigo drug first used for treating vertigo assosicated with Mйni?re's disease. It is also commonly used for patients with balance disorders.
Key Features:
The report on Betahistine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Betahistine market. It may include historical data, market segmentation by Type (e.g., 8mg, 25mg), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Betahistine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Betahistine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Betahistine industry. This include advancements in Betahistine technology, Betahistine new entrants, Betahistine new investment, and other innovations that are shaping the future of Betahistine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Betahistine market. It includes factors influencing customer ' purchasing decisions, preferences for Betahistine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Betahistine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Betahistine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Betahistine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Betahistine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Betahistine market.
Market Segmentation:
Betahistine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- 8mg
- 25mg
- Others
- Cerebral Thrombosis
- Cerebral Embolism
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- TOWA PHARMACEUTICAL CO., LTD
- Nichi-Iko Pharmaceutical
- Takeda Pharmaceutical Company Limited
- EA Pharma Co., Ltd.
- Disphar International B.V.
- HENNIG ARZNEIMITTEL GmbH & Co. KG
- DOC Generici
- Ciclum Farma Unipessoal
- Mylan
- Orion Corporation
What is the 10-year outlook for the global Betahistine market?
What factors are driving Betahistine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Betahistine market opportunities vary by end market size?
How does Betahistine break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Betahistine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Betahistine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Betahistine by Country/Region, 2019, 2023 & 2030
2.2 Betahistine Segment by Type
2.2.1 8mg
2.2.2 25mg
2.2.3 Others
2.3 Betahistine Sales by Type
2.3.1 Global Betahistine Sales Market Share by Type (2019-2024)
2.3.2 Global Betahistine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Betahistine Sale Price by Type (2019-2024)
2.4 Betahistine Segment by Application
2.4.1 Cerebral Thrombosis
2.4.2 Cerebral Embolism
2.4.3 Others
2.5 Betahistine Sales by Application
2.5.1 Global Betahistine Sale Market Share by Application (2019-2024)
2.5.2 Global Betahistine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Betahistine Sale Price by Application (2019-2024)
3 GLOBAL BETAHISTINE BY COMPANY
3.1 Global Betahistine Breakdown Data by Company
3.1.1 Global Betahistine Annual Sales by Company (2019-2024)
3.1.2 Global Betahistine Sales Market Share by Company (2019-2024)
3.2 Global Betahistine Annual Revenue by Company (2019-2024)
3.2.1 Global Betahistine Revenue by Company (2019-2024)
3.2.2 Global Betahistine Revenue Market Share by Company (2019-2024)
3.3 Global Betahistine Sale Price by Company
3.4 Key Manufacturers Betahistine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Betahistine Product Location Distribution
3.4.2 Players Betahistine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BETAHISTINE BY GEOGRAPHIC REGION
4.1 World Historic Betahistine Market Size by Geographic Region (2019-2024)
4.1.1 Global Betahistine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Betahistine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Betahistine Market Size by Country/Region (2019-2024)
4.2.1 Global Betahistine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Betahistine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Betahistine Sales Growth
4.4 APAC Betahistine Sales Growth
4.5 Europe Betahistine Sales Growth
4.6 Middle East & Africa Betahistine Sales Growth
5 AMERICAS
5.1 Americas Betahistine Sales by Country
5.1.1 Americas Betahistine Sales by Country (2019-2024)
5.1.2 Americas Betahistine Revenue by Country (2019-2024)
5.2 Americas Betahistine Sales by Type
5.3 Americas Betahistine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Betahistine Sales by Region
6.1.1 APAC Betahistine Sales by Region (2019-2024)
6.1.2 APAC Betahistine Revenue by Region (2019-2024)
6.2 APAC Betahistine Sales by Type
6.3 APAC Betahistine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Betahistine by Country
7.1.1 Europe Betahistine Sales by Country (2019-2024)
7.1.2 Europe Betahistine Revenue by Country (2019-2024)
7.2 Europe Betahistine Sales by Type
7.3 Europe Betahistine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Betahistine by Country
8.1.1 Middle East & Africa Betahistine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Betahistine Revenue by Country (2019-2024)
8.2 Middle East & Africa Betahistine Sales by Type
8.3 Middle East & Africa Betahistine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Betahistine
10.3 Manufacturing Process Analysis of Betahistine
10.4 Industry Chain Structure of Betahistine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Betahistine Distributors
11.3 Betahistine Customer
12 WORLD FORECAST REVIEW FOR BETAHISTINE BY GEOGRAPHIC REGION
12.1 Global Betahistine Market Size Forecast by Region
12.1.1 Global Betahistine Forecast by Region (2025-2030)
12.1.2 Global Betahistine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Betahistine Forecast by Type
12.7 Global Betahistine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 TOWA PHARMACEUTICAL CO., LTD
13.1.1 TOWA PHARMACEUTICAL CO., LTD Company Information
13.1.2 TOWA PHARMACEUTICAL CO., LTD Betahistine Product Portfolios and Specifications
13.1.3 TOWA PHARMACEUTICAL CO., LTD Betahistine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 TOWA PHARMACEUTICAL CO., LTD Main Business Overview
13.1.5 TOWA PHARMACEUTICAL CO., LTD Latest Developments
13.2 Nichi-Iko Pharmaceutical
13.2.1 Nichi-Iko Pharmaceutical Company Information
13.2.2 Nichi-Iko Pharmaceutical Betahistine Product Portfolios and Specifications
13.2.3 Nichi-Iko Pharmaceutical Betahistine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Nichi-Iko Pharmaceutical Main Business Overview
13.2.5 Nichi-Iko Pharmaceutical Latest Developments
13.3 Takeda Pharmaceutical Company Limited
13.3.1 Takeda Pharmaceutical Company Limited Company Information
13.3.2 Takeda Pharmaceutical Company Limited Betahistine Product Portfolios and Specifications
13.3.3 Takeda Pharmaceutical Company Limited Betahistine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Takeda Pharmaceutical Company Limited Main Business Overview
13.3.5 Takeda Pharmaceutical Company Limited Latest Developments
13.4 EA Pharma Co., Ltd.
13.4.1 EA Pharma Co., Ltd. Company Information
13.4.2 EA Pharma Co., Ltd. Betahistine Product Portfolios and Specifications
13.4.3 EA Pharma Co., Ltd. Betahistine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 EA Pharma Co., Ltd. Main Business Overview
13.4.5 EA Pharma Co., Ltd. Latest Developments
13.5 Disphar International B.V.
13.5.1 Disphar International B.V. Company Information
13.5.2 Disphar International B.V. Betahistine Product Portfolios and Specifications
13.5.3 Disphar International B.V. Betahistine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Disphar International B.V. Main Business Overview
13.5.5 Disphar International B.V. Latest Developments
13.6 HENNIG ARZNEIMITTEL GmbH & Co. KG
13.6.1 HENNIG ARZNEIMITTEL GmbH & Co. KG Company Information
13.6.2 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product Portfolios and Specifications
13.6.3 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 HENNIG ARZNEIMITTEL GmbH & Co. KG Main Business Overview
13.6.5 HENNIG ARZNEIMITTEL GmbH & Co. KG Latest Developments
13.7 DOC Generici
13.7.1 DOC Generici Company Information
13.7.2 DOC Generici Betahistine Product Portfolios and Specifications
13.7.3 DOC Generici Betahistine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 DOC Generici Main Business Overview
13.7.5 DOC Generici Latest Developments
13.8 Ciclum Farma Unipessoal
13.8.1 Ciclum Farma Unipessoal Company Information
13.8.2 Ciclum Farma Unipessoal Betahistine Product Portfolios and Specifications
13.8.3 Ciclum Farma Unipessoal Betahistine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Ciclum Farma Unipessoal Main Business Overview
13.8.5 Ciclum Farma Unipessoal Latest Developments
13.9 Mylan
13.9.1 Mylan Company Information
13.9.2 Mylan Betahistine Product Portfolios and Specifications
13.9.3 Mylan Betahistine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Mylan Main Business Overview
13.9.5 Mylan Latest Developments
13.10 Orion Corporation
13.10.1 Orion Corporation Company Information
13.10.2 Orion Corporation Betahistine Product Portfolios and Specifications
13.10.3 Orion Corporation Betahistine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Orion Corporation Main Business Overview
13.10.5 Orion Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Betahistine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Betahistine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Betahistine by Country/Region, 2019, 2023 & 2030
2.2 Betahistine Segment by Type
2.2.1 8mg
2.2.2 25mg
2.2.3 Others
2.3 Betahistine Sales by Type
2.3.1 Global Betahistine Sales Market Share by Type (2019-2024)
2.3.2 Global Betahistine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Betahistine Sale Price by Type (2019-2024)
2.4 Betahistine Segment by Application
2.4.1 Cerebral Thrombosis
2.4.2 Cerebral Embolism
2.4.3 Others
2.5 Betahistine Sales by Application
2.5.1 Global Betahistine Sale Market Share by Application (2019-2024)
2.5.2 Global Betahistine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Betahistine Sale Price by Application (2019-2024)
3 GLOBAL BETAHISTINE BY COMPANY
3.1 Global Betahistine Breakdown Data by Company
3.1.1 Global Betahistine Annual Sales by Company (2019-2024)
3.1.2 Global Betahistine Sales Market Share by Company (2019-2024)
3.2 Global Betahistine Annual Revenue by Company (2019-2024)
3.2.1 Global Betahistine Revenue by Company (2019-2024)
3.2.2 Global Betahistine Revenue Market Share by Company (2019-2024)
3.3 Global Betahistine Sale Price by Company
3.4 Key Manufacturers Betahistine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Betahistine Product Location Distribution
3.4.2 Players Betahistine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BETAHISTINE BY GEOGRAPHIC REGION
4.1 World Historic Betahistine Market Size by Geographic Region (2019-2024)
4.1.1 Global Betahistine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Betahistine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Betahistine Market Size by Country/Region (2019-2024)
4.2.1 Global Betahistine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Betahistine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Betahistine Sales Growth
4.4 APAC Betahistine Sales Growth
4.5 Europe Betahistine Sales Growth
4.6 Middle East & Africa Betahistine Sales Growth
5 AMERICAS
5.1 Americas Betahistine Sales by Country
5.1.1 Americas Betahistine Sales by Country (2019-2024)
5.1.2 Americas Betahistine Revenue by Country (2019-2024)
5.2 Americas Betahistine Sales by Type
5.3 Americas Betahistine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Betahistine Sales by Region
6.1.1 APAC Betahistine Sales by Region (2019-2024)
6.1.2 APAC Betahistine Revenue by Region (2019-2024)
6.2 APAC Betahistine Sales by Type
6.3 APAC Betahistine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Betahistine by Country
7.1.1 Europe Betahistine Sales by Country (2019-2024)
7.1.2 Europe Betahistine Revenue by Country (2019-2024)
7.2 Europe Betahistine Sales by Type
7.3 Europe Betahistine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Betahistine by Country
8.1.1 Middle East & Africa Betahistine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Betahistine Revenue by Country (2019-2024)
8.2 Middle East & Africa Betahistine Sales by Type
8.3 Middle East & Africa Betahistine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Betahistine
10.3 Manufacturing Process Analysis of Betahistine
10.4 Industry Chain Structure of Betahistine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Betahistine Distributors
11.3 Betahistine Customer
12 WORLD FORECAST REVIEW FOR BETAHISTINE BY GEOGRAPHIC REGION
12.1 Global Betahistine Market Size Forecast by Region
12.1.1 Global Betahistine Forecast by Region (2025-2030)
12.1.2 Global Betahistine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Betahistine Forecast by Type
12.7 Global Betahistine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 TOWA PHARMACEUTICAL CO., LTD
13.1.1 TOWA PHARMACEUTICAL CO., LTD Company Information
13.1.2 TOWA PHARMACEUTICAL CO., LTD Betahistine Product Portfolios and Specifications
13.1.3 TOWA PHARMACEUTICAL CO., LTD Betahistine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 TOWA PHARMACEUTICAL CO., LTD Main Business Overview
13.1.5 TOWA PHARMACEUTICAL CO., LTD Latest Developments
13.2 Nichi-Iko Pharmaceutical
13.2.1 Nichi-Iko Pharmaceutical Company Information
13.2.2 Nichi-Iko Pharmaceutical Betahistine Product Portfolios and Specifications
13.2.3 Nichi-Iko Pharmaceutical Betahistine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Nichi-Iko Pharmaceutical Main Business Overview
13.2.5 Nichi-Iko Pharmaceutical Latest Developments
13.3 Takeda Pharmaceutical Company Limited
13.3.1 Takeda Pharmaceutical Company Limited Company Information
13.3.2 Takeda Pharmaceutical Company Limited Betahistine Product Portfolios and Specifications
13.3.3 Takeda Pharmaceutical Company Limited Betahistine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Takeda Pharmaceutical Company Limited Main Business Overview
13.3.5 Takeda Pharmaceutical Company Limited Latest Developments
13.4 EA Pharma Co., Ltd.
13.4.1 EA Pharma Co., Ltd. Company Information
13.4.2 EA Pharma Co., Ltd. Betahistine Product Portfolios and Specifications
13.4.3 EA Pharma Co., Ltd. Betahistine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 EA Pharma Co., Ltd. Main Business Overview
13.4.5 EA Pharma Co., Ltd. Latest Developments
13.5 Disphar International B.V.
13.5.1 Disphar International B.V. Company Information
13.5.2 Disphar International B.V. Betahistine Product Portfolios and Specifications
13.5.3 Disphar International B.V. Betahistine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Disphar International B.V. Main Business Overview
13.5.5 Disphar International B.V. Latest Developments
13.6 HENNIG ARZNEIMITTEL GmbH & Co. KG
13.6.1 HENNIG ARZNEIMITTEL GmbH & Co. KG Company Information
13.6.2 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product Portfolios and Specifications
13.6.3 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 HENNIG ARZNEIMITTEL GmbH & Co. KG Main Business Overview
13.6.5 HENNIG ARZNEIMITTEL GmbH & Co. KG Latest Developments
13.7 DOC Generici
13.7.1 DOC Generici Company Information
13.7.2 DOC Generici Betahistine Product Portfolios and Specifications
13.7.3 DOC Generici Betahistine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 DOC Generici Main Business Overview
13.7.5 DOC Generici Latest Developments
13.8 Ciclum Farma Unipessoal
13.8.1 Ciclum Farma Unipessoal Company Information
13.8.2 Ciclum Farma Unipessoal Betahistine Product Portfolios and Specifications
13.8.3 Ciclum Farma Unipessoal Betahistine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Ciclum Farma Unipessoal Main Business Overview
13.8.5 Ciclum Farma Unipessoal Latest Developments
13.9 Mylan
13.9.1 Mylan Company Information
13.9.2 Mylan Betahistine Product Portfolios and Specifications
13.9.3 Mylan Betahistine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Mylan Main Business Overview
13.9.5 Mylan Latest Developments
13.10 Orion Corporation
13.10.1 Orion Corporation Company Information
13.10.2 Orion Corporation Betahistine Product Portfolios and Specifications
13.10.3 Orion Corporation Betahistine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Orion Corporation Main Business Overview
13.10.5 Orion Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Betahistine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Betahistine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 8mg
Table 4. Major Players of 25mg
Table 5. Major Players of Others
Table 6. Global Betahistine Sales by Type (2019-2024) & (K Units)
Table 7. Global Betahistine Sales Market Share by Type (2019-2024)
Table 8. Global Betahistine Revenue by Type (2019-2024) & ($ million)
Table 9. Global Betahistine Revenue Market Share by Type (2019-2024)
Table 10. Global Betahistine Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global Betahistine Sales by Application (2019-2024) & (K Units)
Table 12. Global Betahistine Sales Market Share by Application (2019-2024)
Table 13. Global Betahistine Revenue by Application (2019-2024)
Table 14. Global Betahistine Revenue Market Share by Application (2019-2024)
Table 15. Global Betahistine Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Betahistine Sales by Company (2019-2024) & (K Units)
Table 17. Global Betahistine Sales Market Share by Company (2019-2024)
Table 18. Global Betahistine Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Betahistine Revenue Market Share by Company (2019-2024)
Table 20. Global Betahistine Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Betahistine Producing Area Distribution and Sales Area
Table 22. Players Betahistine Products Offered
Table 23. Betahistine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Betahistine Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Betahistine Sales Market Share Geographic Region (2019-2024)
Table 28. Global Betahistine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Betahistine Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Betahistine Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Betahistine Sales Market Share by Country/Region (2019-2024)
Table 32. Global Betahistine Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Betahistine Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Betahistine Sales by Country (2019-2024) & (K Units)
Table 35. Americas Betahistine Sales Market Share by Country (2019-2024)
Table 36. Americas Betahistine Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Betahistine Revenue Market Share by Country (2019-2024)
Table 38. Americas Betahistine Sales by Type (2019-2024) & (K Units)
Table 39. Americas Betahistine Sales by Application (2019-2024) & (K Units)
Table 40. APAC Betahistine Sales by Region (2019-2024) & (K Units)
Table 41. APAC Betahistine Sales Market Share by Region (2019-2024)
Table 42. APAC Betahistine Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Betahistine Revenue Market Share by Region (2019-2024)
Table 44. APAC Betahistine Sales by Type (2019-2024) & (K Units)
Table 45. APAC Betahistine Sales by Application (2019-2024) & (K Units)
Table 46. Europe Betahistine Sales by Country (2019-2024) & (K Units)
Table 47. Europe Betahistine Sales Market Share by Country (2019-2024)
Table 48. Europe Betahistine Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Betahistine Revenue Market Share by Country (2019-2024)
Table 50. Europe Betahistine Sales by Type (2019-2024) & (K Units)
Table 51. Europe Betahistine Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Betahistine Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Betahistine Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Betahistine Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Betahistine Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Betahistine Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Betahistine Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Betahistine
Table 59. Key Market Challenges & Risks of Betahistine
Table 60. Key Industry Trends of Betahistine
Table 61. Betahistine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Betahistine Distributors List
Table 64. Betahistine Customer List
Table 65. Global Betahistine Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Betahistine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Betahistine Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Betahistine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Betahistine Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Betahistine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Betahistine Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Betahistine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Betahistine Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Betahistine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Betahistine Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Betahistine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Betahistine Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Betahistine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. TOWA PHARMACEUTICAL CO., LTD Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 80. TOWA PHARMACEUTICAL CO., LTD Betahistine Product Portfolios and Specifications
Table 81. TOWA PHARMACEUTICAL CO., LTD Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. TOWA PHARMACEUTICAL CO., LTD Main Business
Table 83. TOWA PHARMACEUTICAL CO., LTD Latest Developments
Table 84. Nichi-Iko Pharmaceutical Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 85. Nichi-Iko Pharmaceutical Betahistine Product Portfolios and Specifications
Table 86. Nichi-Iko Pharmaceutical Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Nichi-Iko Pharmaceutical Main Business
Table 88. Nichi-Iko Pharmaceutical Latest Developments
Table 89. Takeda Pharmaceutical Company Limited Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 90. Takeda Pharmaceutical Company Limited Betahistine Product Portfolios and Specifications
Table 91. Takeda Pharmaceutical Company Limited Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Takeda Pharmaceutical Company Limited Main Business
Table 93. Takeda Pharmaceutical Company Limited Latest Developments
Table 94. EA Pharma Co., Ltd. Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 95. EA Pharma Co., Ltd. Betahistine Product Portfolios and Specifications
Table 96. EA Pharma Co., Ltd. Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. EA Pharma Co., Ltd. Main Business
Table 98. EA Pharma Co., Ltd. Latest Developments
Table 99. Disphar International B.V. Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 100. Disphar International B.V. Betahistine Product Portfolios and Specifications
Table 101. Disphar International B.V. Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. Disphar International B.V. Main Business
Table 103. Disphar International B.V. Latest Developments
Table 104. HENNIG ARZNEIMITTEL GmbH & Co. KG Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 105. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product Portfolios and Specifications
Table 106. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 107. HENNIG ARZNEIMITTEL GmbH & Co. KG Main Business
Table 108. HENNIG ARZNEIMITTEL GmbH & Co. KG Latest Developments
Table 109. DOC Generici Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 110. DOC Generici Betahistine Product Portfolios and Specifications
Table 111. DOC Generici Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. DOC Generici Main Business
Table 113. DOC Generici Latest Developments
Table 114. Ciclum Farma Unipessoal Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 115. Ciclum Farma Unipessoal Betahistine Product Portfolios and Specifications
Table 116. Ciclum Farma Unipessoal Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 117. Ciclum Farma Unipessoal Main Business
Table 118. Ciclum Farma Unipessoal Latest Developments
Table 119. Mylan Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 120. Mylan Betahistine Product Portfolios and Specifications
Table 121. Mylan Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 122. Mylan Main Business
Table 123. Mylan Latest Developments
Table 124. Orion Corporation Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 125. Orion Corporation Betahistine Product Portfolios and Specifications
Table 126. Orion Corporation Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 127. Orion Corporation Main Business
Table 128. Orion Corporation Latest Developments
Table 1. Betahistine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Betahistine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 8mg
Table 4. Major Players of 25mg
Table 5. Major Players of Others
Table 6. Global Betahistine Sales by Type (2019-2024) & (K Units)
Table 7. Global Betahistine Sales Market Share by Type (2019-2024)
Table 8. Global Betahistine Revenue by Type (2019-2024) & ($ million)
Table 9. Global Betahistine Revenue Market Share by Type (2019-2024)
Table 10. Global Betahistine Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global Betahistine Sales by Application (2019-2024) & (K Units)
Table 12. Global Betahistine Sales Market Share by Application (2019-2024)
Table 13. Global Betahistine Revenue by Application (2019-2024)
Table 14. Global Betahistine Revenue Market Share by Application (2019-2024)
Table 15. Global Betahistine Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Betahistine Sales by Company (2019-2024) & (K Units)
Table 17. Global Betahistine Sales Market Share by Company (2019-2024)
Table 18. Global Betahistine Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Betahistine Revenue Market Share by Company (2019-2024)
Table 20. Global Betahistine Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Betahistine Producing Area Distribution and Sales Area
Table 22. Players Betahistine Products Offered
Table 23. Betahistine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Betahistine Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Betahistine Sales Market Share Geographic Region (2019-2024)
Table 28. Global Betahistine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Betahistine Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Betahistine Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Betahistine Sales Market Share by Country/Region (2019-2024)
Table 32. Global Betahistine Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Betahistine Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Betahistine Sales by Country (2019-2024) & (K Units)
Table 35. Americas Betahistine Sales Market Share by Country (2019-2024)
Table 36. Americas Betahistine Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Betahistine Revenue Market Share by Country (2019-2024)
Table 38. Americas Betahistine Sales by Type (2019-2024) & (K Units)
Table 39. Americas Betahistine Sales by Application (2019-2024) & (K Units)
Table 40. APAC Betahistine Sales by Region (2019-2024) & (K Units)
Table 41. APAC Betahistine Sales Market Share by Region (2019-2024)
Table 42. APAC Betahistine Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Betahistine Revenue Market Share by Region (2019-2024)
Table 44. APAC Betahistine Sales by Type (2019-2024) & (K Units)
Table 45. APAC Betahistine Sales by Application (2019-2024) & (K Units)
Table 46. Europe Betahistine Sales by Country (2019-2024) & (K Units)
Table 47. Europe Betahistine Sales Market Share by Country (2019-2024)
Table 48. Europe Betahistine Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Betahistine Revenue Market Share by Country (2019-2024)
Table 50. Europe Betahistine Sales by Type (2019-2024) & (K Units)
Table 51. Europe Betahistine Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Betahistine Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Betahistine Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Betahistine Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Betahistine Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Betahistine Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Betahistine Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Betahistine
Table 59. Key Market Challenges & Risks of Betahistine
Table 60. Key Industry Trends of Betahistine
Table 61. Betahistine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Betahistine Distributors List
Table 64. Betahistine Customer List
Table 65. Global Betahistine Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Betahistine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Betahistine Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Betahistine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Betahistine Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Betahistine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Betahistine Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Betahistine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Betahistine Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Betahistine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Betahistine Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Betahistine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Betahistine Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Betahistine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. TOWA PHARMACEUTICAL CO., LTD Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 80. TOWA PHARMACEUTICAL CO., LTD Betahistine Product Portfolios and Specifications
Table 81. TOWA PHARMACEUTICAL CO., LTD Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. TOWA PHARMACEUTICAL CO., LTD Main Business
Table 83. TOWA PHARMACEUTICAL CO., LTD Latest Developments
Table 84. Nichi-Iko Pharmaceutical Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 85. Nichi-Iko Pharmaceutical Betahistine Product Portfolios and Specifications
Table 86. Nichi-Iko Pharmaceutical Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Nichi-Iko Pharmaceutical Main Business
Table 88. Nichi-Iko Pharmaceutical Latest Developments
Table 89. Takeda Pharmaceutical Company Limited Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 90. Takeda Pharmaceutical Company Limited Betahistine Product Portfolios and Specifications
Table 91. Takeda Pharmaceutical Company Limited Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Takeda Pharmaceutical Company Limited Main Business
Table 93. Takeda Pharmaceutical Company Limited Latest Developments
Table 94. EA Pharma Co., Ltd. Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 95. EA Pharma Co., Ltd. Betahistine Product Portfolios and Specifications
Table 96. EA Pharma Co., Ltd. Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. EA Pharma Co., Ltd. Main Business
Table 98. EA Pharma Co., Ltd. Latest Developments
Table 99. Disphar International B.V. Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 100. Disphar International B.V. Betahistine Product Portfolios and Specifications
Table 101. Disphar International B.V. Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. Disphar International B.V. Main Business
Table 103. Disphar International B.V. Latest Developments
Table 104. HENNIG ARZNEIMITTEL GmbH & Co. KG Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 105. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product Portfolios and Specifications
Table 106. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 107. HENNIG ARZNEIMITTEL GmbH & Co. KG Main Business
Table 108. HENNIG ARZNEIMITTEL GmbH & Co. KG Latest Developments
Table 109. DOC Generici Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 110. DOC Generici Betahistine Product Portfolios and Specifications
Table 111. DOC Generici Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. DOC Generici Main Business
Table 113. DOC Generici Latest Developments
Table 114. Ciclum Farma Unipessoal Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 115. Ciclum Farma Unipessoal Betahistine Product Portfolios and Specifications
Table 116. Ciclum Farma Unipessoal Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 117. Ciclum Farma Unipessoal Main Business
Table 118. Ciclum Farma Unipessoal Latest Developments
Table 119. Mylan Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 120. Mylan Betahistine Product Portfolios and Specifications
Table 121. Mylan Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 122. Mylan Main Business
Table 123. Mylan Latest Developments
Table 124. Orion Corporation Basic Information, Betahistine Manufacturing Base, Sales Area and Its Competitors
Table 125. Orion Corporation Betahistine Product Portfolios and Specifications
Table 126. Orion Corporation Betahistine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 127. Orion Corporation Main Business
Table 128. Orion Corporation Latest Developments
LIST OF FIGURES
Figure 1. Picture of Betahistine
Figure 2. Betahistine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Betahistine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Betahistine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Betahistine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of 8mg
Figure 10. Product Picture of 25mg
Figure 11. Product Picture of Others
Figure 12. Global Betahistine Sales Market Share by Type in 2023
Figure 13. Global Betahistine Revenue Market Share by Type (2019-2024)
Figure 14. Betahistine Consumed in Cerebral Thrombosis
Figure 15. Global Betahistine Market: Cerebral Thrombosis (2019-2024) & (K Units)
Figure 16. Betahistine Consumed in Cerebral Embolism
Figure 17. Global Betahistine Market: Cerebral Embolism (2019-2024) & (K Units)
Figure 18. Betahistine Consumed in Others
Figure 19. Global Betahistine Market: Others (2019-2024) & (K Units)
Figure 20. Global Betahistine Sales Market Share by Application (2023)
Figure 21. Global Betahistine Revenue Market Share by Application in 2023
Figure 22. Betahistine Sales Market by Company in 2023 (K Units)
Figure 23. Global Betahistine Sales Market Share by Company in 2023
Figure 24. Betahistine Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Betahistine Revenue Market Share by Company in 2023
Figure 26. Global Betahistine Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Betahistine Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Betahistine Sales 2019-2024 (K Units)
Figure 29. Americas Betahistine Revenue 2019-2024 ($ Millions)
Figure 30. APAC Betahistine Sales 2019-2024 (K Units)
Figure 31. APAC Betahistine Revenue 2019-2024 ($ Millions)
Figure 32. Europe Betahistine Sales 2019-2024 (K Units)
Figure 33. Europe Betahistine Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Betahistine Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Betahistine Revenue 2019-2024 ($ Millions)
Figure 36. Americas Betahistine Sales Market Share by Country in 2023
Figure 37. Americas Betahistine Revenue Market Share by Country in 2023
Figure 38. Americas Betahistine Sales Market Share by Type (2019-2024)
Figure 39. Americas Betahistine Sales Market Share by Application (2019-2024)
Figure 40. United States Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Betahistine Sales Market Share by Region in 2023
Figure 45. APAC Betahistine Revenue Market Share by Regions in 2023
Figure 46. APAC Betahistine Sales Market Share by Type (2019-2024)
Figure 47. APAC Betahistine Sales Market Share by Application (2019-2024)
Figure 48. China Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Betahistine Sales Market Share by Country in 2023
Figure 56. Europe Betahistine Revenue Market Share by Country in 2023
Figure 57. Europe Betahistine Sales Market Share by Type (2019-2024)
Figure 58. Europe Betahistine Sales Market Share by Application (2019-2024)
Figure 59. Germany Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Betahistine Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Betahistine Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Betahistine Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Betahistine Sales Market Share by Application (2019-2024)
Figure 68. Egypt Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Betahistine in 2023
Figure 74. Manufacturing Process Analysis of Betahistine
Figure 75. Industry Chain Structure of Betahistine
Figure 76. Channels of Distribution
Figure 77. Global Betahistine Sales Market Forecast by Region (2025-2030)
Figure 78. Global Betahistine Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Betahistine Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Betahistine Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Betahistine Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Betahistine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Betahistine
Figure 2. Betahistine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Betahistine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Betahistine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Betahistine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of 8mg
Figure 10. Product Picture of 25mg
Figure 11. Product Picture of Others
Figure 12. Global Betahistine Sales Market Share by Type in 2023
Figure 13. Global Betahistine Revenue Market Share by Type (2019-2024)
Figure 14. Betahistine Consumed in Cerebral Thrombosis
Figure 15. Global Betahistine Market: Cerebral Thrombosis (2019-2024) & (K Units)
Figure 16. Betahistine Consumed in Cerebral Embolism
Figure 17. Global Betahistine Market: Cerebral Embolism (2019-2024) & (K Units)
Figure 18. Betahistine Consumed in Others
Figure 19. Global Betahistine Market: Others (2019-2024) & (K Units)
Figure 20. Global Betahistine Sales Market Share by Application (2023)
Figure 21. Global Betahistine Revenue Market Share by Application in 2023
Figure 22. Betahistine Sales Market by Company in 2023 (K Units)
Figure 23. Global Betahistine Sales Market Share by Company in 2023
Figure 24. Betahistine Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Betahistine Revenue Market Share by Company in 2023
Figure 26. Global Betahistine Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Betahistine Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Betahistine Sales 2019-2024 (K Units)
Figure 29. Americas Betahistine Revenue 2019-2024 ($ Millions)
Figure 30. APAC Betahistine Sales 2019-2024 (K Units)
Figure 31. APAC Betahistine Revenue 2019-2024 ($ Millions)
Figure 32. Europe Betahistine Sales 2019-2024 (K Units)
Figure 33. Europe Betahistine Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Betahistine Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Betahistine Revenue 2019-2024 ($ Millions)
Figure 36. Americas Betahistine Sales Market Share by Country in 2023
Figure 37. Americas Betahistine Revenue Market Share by Country in 2023
Figure 38. Americas Betahistine Sales Market Share by Type (2019-2024)
Figure 39. Americas Betahistine Sales Market Share by Application (2019-2024)
Figure 40. United States Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Betahistine Sales Market Share by Region in 2023
Figure 45. APAC Betahistine Revenue Market Share by Regions in 2023
Figure 46. APAC Betahistine Sales Market Share by Type (2019-2024)
Figure 47. APAC Betahistine Sales Market Share by Application (2019-2024)
Figure 48. China Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Betahistine Sales Market Share by Country in 2023
Figure 56. Europe Betahistine Revenue Market Share by Country in 2023
Figure 57. Europe Betahistine Sales Market Share by Type (2019-2024)
Figure 58. Europe Betahistine Sales Market Share by Application (2019-2024)
Figure 59. Germany Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Betahistine Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Betahistine Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Betahistine Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Betahistine Sales Market Share by Application (2019-2024)
Figure 68. Egypt Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Betahistine Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Betahistine in 2023
Figure 74. Manufacturing Process Analysis of Betahistine
Figure 75. Industry Chain Structure of Betahistine
Figure 76. Channels of Distribution
Figure 77. Global Betahistine Sales Market Forecast by Region (2025-2030)
Figure 78. Global Betahistine Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Betahistine Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Betahistine Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Betahistine Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Betahistine Revenue Market Share Forecast by Application (2025-2030)
